文献速递功能神经外科

伽玛刀放射外科治疗多发性硬化相关三叉神经痛

Gamma Knife Radiosurgery for Multiple Sclerosis-Associated Trigeminal Neuralgia.
PubMed 文献 · Neurosurgery · 2019-01-01

该回顾性队列研究纳入74例多发性硬化相关三叉神经痛(MS-TN)患者的77例单侧病例,其中37例接受重复伽玛刀(GKRS)。结论认为GKRS对MS-TN有效且耐受良好,重复GKRS常可获得更持久缓解。

要点

  • 与历史队列相比,MS-TN初次GKRS后缓解持续时间更短。

核心结论

  • GKRS是MS-TN有效且耐受良好的治疗方法,重复GKRS常可获得更持久缓解。

研究设计与样本

  • 回顾性队列研究,纳入2001至2016年接受GKRS的74例患者共77例单侧MS-TN,其中37例接受重复GKRS。

主要发现

  • 与本院历史队列相比,MS-TN初次GKRS后BNI IIIb或更好缓解持续时间更短(4.6 vs 1.1年),重复GKRS后无差异(3.8 vs 4.0年)。

关键数值与推荐

  • 初次GKRS中位剂量为85 Gy至100%等剂量线,重复GKRS中位剂量为80 Gy至100%等剂量线。

临床怎么用

  • 对于MS-TN患者,GKRS可作为有效且耐受良好的治疗选择,重复GKRS可用于获得更持久疼痛缓解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trigeminal neuralgia in the setting of multiple sclerosis (MS-TN) is a challenging condition to manage that is commonly treated with Gamma Knife radiosurgery (GKRS; Elekta AB). However, data regarding the efficacy of this treatment are somewhat limited, particularly for repeat GKRS. OBJECTIVE: To report outcomes of GKRS for MS-TN from a cohort study. METHODS: Retrospective review of our GKRS database identified 77 cases of unilateral MS-TN (UMSTN) in 74 patients treated with GKRS between 2001 and 2016, with 37 cases undergoing repeat GKRS. Background medical history, treatment outcomes and complications, and dosimetric data were obtained by retrospective chart reviews and telephone interviews. RESULTS: Eighty-two percent of UMSTN cases achieved Barrow Neurological Institute (BNI) IIIb or better pain relief following initial GKRS for a median duration of 1.1 yr. Estimated rates of pain relief at 1, 3, and 5 yr were 51, 39, and 29% respectively. Eighty-eight percent achieved BNI IIIb or better pain relief after repeat GKRS for a median duration of 4.0 yr. Estimated rates of pain relief at 1 and 3 yr were 70 and 54%, respectively. Median doses for initial and repeat GKRS were 85 and 80 Gy to the 100% isodose line, respectively. Those with MS-TN had a shorter duration of BNI IIIb or better pain relief after initial (4.6 vs 1.1 yr), but not repeat GKRS (3.8 vs 4.0 yr) compared to a historical cohort from our institution. CONCLUSION: GKRS is an effective, well-tolerated treatment for patients with MS-TN. More durable relief is often achieved with repeat GKRS.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Helis CA, McTyre E, Munley MT, et al. Gamma Knife Radiosurgery for Multiple Sclerosis-Associated Trigeminal Neuralgia. Neurosurgery. 2019. PMID: 31173108. doi:10.1093/neuros/nyz182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。